1. Home
  2. HOLO vs OGEN Comparison

HOLO vs OGEN Comparison

Compare HOLO & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOLO
  • OGEN
  • Stock Information
  • Founded
  • HOLO 2018
  • OGEN 1996
  • Country
  • HOLO China
  • OGEN United States
  • Employees
  • HOLO N/A
  • OGEN N/A
  • Industry
  • HOLO Computer Software: Programming Data Processing
  • OGEN Biotechnology: Pharmaceutical Preparations
  • Sector
  • HOLO Technology
  • OGEN Health Care
  • Exchange
  • HOLO Nasdaq
  • OGEN Nasdaq
  • Market Cap
  • HOLO 24.9M
  • OGEN 2.5M
  • IPO Year
  • HOLO N/A
  • OGEN N/A
  • Fundamental
  • Price
  • HOLO $6.09
  • OGEN $1.43
  • Analyst Decision
  • HOLO
  • OGEN
  • Analyst Count
  • HOLO 0
  • OGEN 0
  • Target Price
  • HOLO N/A
  • OGEN N/A
  • AVG Volume (30 Days)
  • HOLO 4.4M
  • OGEN 1.2M
  • Earning Date
  • HOLO 01-01-0001
  • OGEN 08-08-2025
  • Dividend Yield
  • HOLO N/A
  • OGEN N/A
  • EPS Growth
  • HOLO N/A
  • OGEN N/A
  • EPS
  • HOLO N/A
  • OGEN N/A
  • Revenue
  • HOLO $39,771,750.00
  • OGEN N/A
  • Revenue This Year
  • HOLO N/A
  • OGEN N/A
  • Revenue Next Year
  • HOLO N/A
  • OGEN N/A
  • P/E Ratio
  • HOLO N/A
  • OGEN N/A
  • Revenue Growth
  • HOLO 42.62
  • OGEN N/A
  • 52 Week Low
  • HOLO $4.16
  • OGEN $1.32
  • 52 Week High
  • HOLO $608.00
  • OGEN $75.60
  • Technical
  • Relative Strength Index (RSI)
  • HOLO 53.39
  • OGEN 27.81
  • Support Level
  • HOLO $4.84
  • OGEN $1.32
  • Resistance Level
  • HOLO $6.20
  • OGEN $1.58
  • Average True Range (ATR)
  • HOLO 0.46
  • OGEN 0.27
  • MACD
  • HOLO 0.37
  • OGEN -0.09
  • Stochastic Oscillator
  • HOLO 91.11
  • OGEN 4.53

About HOLO MicroCloud Hologram Inc.

MicroCloud Hologram Inc, through its subsidiaries, is mainly engaged in holographic Technology. It includes Holographic solutions and Holographic technology services. The company also provides holographic digital twin technology services for customers and has built a holographic digital twin technology resource library. Geographically company is operating in single segment, China.

About OGEN Oragenics Inc.

Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. The Company operates in one reportable segment, which includes activities related to advancing the development of its concussion drug, ONP-002.

Share on Social Networks: